10.3978/j.issn.1000-9604.2014.04.01
The changing world of drug development
Drug development in oncology is undergoing a substantial shift nowadays.The drivers for this are multi-factorial.On the one side,drug development is performed more rationally than ever,profiting from the scientific advances in molecular biology in general and the elucidation of the various ”omes” from genome to metabolome in particular.On the other side,it is based on enormous technological progress,e.g.,in the field of genome sequencing,and in that of adequate handling of the resulting plethora of data.The high attrition rate of oncologic drugs under development in the past and the pressure from the side of the payers make it necessary to find permanently new answers for and adaptations of the process of drug development.In this context,it is necessary to respect arguments and views from the various perspectives of all the relevant stakeholders.
technological progress、molecular biology
26
TG1;F40
2014-07-01(万方平台首次上网日期,不代表论文的发表时间)
共1页
132